search
clinical researchers
Trends
- 1Clinical Trial Data Exposed in Academic Database BreachesโClinical trial data including genetic and medical history information has been exposed in academic research database bre
Breaches of academic research databases have exposed clinical trial data, including genetic and medical history information, affecting thousands of trial participants. Privacy advocates are urging people to exercise their rights under HIPAA, which allows patients to obtain their medical records and a list of everyone those records were shared with, and to request corrections where needed.
- 2AI Clinical Monitoring Tool Reported to Cut Trial Costs by MillionsโผAI Clinical Monitoring Tool Saves Millions in Trial Costs
An AI-powered clinical monitoring tool is reported to have saved millions of dollars in clinical trial costs, according to coverage in The Scientist. The tool is said to streamline monitoring of trial sites, reducing manual oversight work and associated expenses. The report highlights growing interest in applying artificial intelligence to make drug development faster and cheaper, though detailed figures and trial specifics were not provided.
- 3Epigenetic Editing Moves Closer to Clinical UseโEpigenetic Editing Steps Closer to the Clinic as Bioengineering Tools Mature
Epigenetic editing, which alters gene activity without changing DNA sequence, is reportedly approaching clinical application as bioengineering tools mature. Advances in gene-regulation technologies are making it feasible to target epigenetic marks precisely, opening the door to therapies for diseases rooted in gene expression rather than genetic mutations. The development signals a shift from laboratory research toward translational medicine, with researchers watching how safety and delivery challenges are addressed.
- 4Could age explain conflicting psychedelic study results?โCould age help explain why psychedelic studies reach different conclusions?
Researchers are examining whether participants' age may help explain why psychedelic studies reach different conclusions. Older adults may respond differently to psychedelic therapies than younger participants, which could account for variability across trials. The question matters as psychedelics move closer to regulated clinical use for depression and other mental health conditions.
- 5Highlights from World Cancer Congress 2026, Part TwoโHighlights from World Cancer Congress 2026 โ Part 2
Part two of a roundup of highlights from the World Cancer Congress 2026 has been published, covering key presentations, research findings and discussions from the global oncology meeting. The continued coverage suggests sustained interest in developments presented at the congress among cancer researchers and clinicians worldwide.
- 6Eric Deutsch on the Fast-Growing Science Linking Radiation Oncology and ImmunologyโEric Deutsch: The Science Is Expanding Fast at the Interface of Radiation Oncology, Immunology, and Technology
Radiation oncology expert Eric Deutsch says science is expanding rapidly at the intersection of radiation therapy, immunology, and technology, as combined approaches such as radiotherapy paired with immunotherapy gain ground in cancer treatment. His remarks highlight how technological advances and immune-based research are reshaping how clinicians think about radiation's role beyond tumour destruction.